Figure 3.
In vitro dose-dependent nanovector internalization and GFP knockdown. (a) Uptake of nanovectors by target cells. (b) Efficiency of nanovector treatments on silencing GFP expression in C6/GFP+.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.